Clinical Trials Logo

Other clinical trials

View clinical trials related to Other.

Filter by:

NCT ID: NCT01694641 Terminated - Clinical trials for Clinical Pregnancy After Single Embryo Transfer

Embryo Selection by Time Lapse Monitoring for Single Embryo Transfer ("SET")

Start date: July 2012
Phase: Phase 4
Study type: Interventional

A multiple pregnancy is an undesired outcome of assisted reproduction. Current embryo selection technologies are inefficient in identifying the embryo with the highest implantation potential. Time lapse (TL) embryo monitoring provides additional information about embryo development and therefore may aid embryo selection. The investigators aim is to study whether TL monitoring is superior to traditional embryo observation when a single blastocyst is selected for transfer (ET).

NCT ID: NCT01690715 Terminated - Clinical trials for Hepatocellular Carcinoma

Prognostic Value Related to the Presence of Thrombosis or Portal Vein Invasion in Patients With Hepatocellular Carcinoma Submitted to Surgery

HSL2012-06
Start date: July 2012
Phase:
Study type: Observational

A retrospective study based on analysis of medical records of patients with hepatocellular carcinoma treated at the Hospital Sírio-Libanês (Sao Paulo-Brazil) between 2001 and 2011 with diagnosis confirmed by imaging or histological specimen underwent surgical resection with curative intent. The study aims to determine the prognostic value of vascular complications related to cancer and to evaluate the survival rate of these patients, comparing the data with those reported in the literature.

NCT ID: NCT01690156 Terminated - Clinical trials for In-plane Ultrasound-guided Regional Anesthesia Performance

Trial on the Effects of Ultrasound Probe Position on Ultrasound-guided Nerve Blocks

Start date: August 2012
Phase:
Study type: Observational

Ultrasound has been used to guide a needle to inject local anesthetics around nerves. This is usually done in the same plane as the ultrasound beam in America and is known as an in-plane technique. When done correctly, the entire needle is visualized on the ultrasound screen as it approaches the nerves which are also seen on the same screen the entire time. The ultrasound probe can be held perpendicular or parallel to the shoulders of the person performing the in-plane technique. Our hypothesis is that holding the ultrasound probe perpendicular to the shoulder is superior to holding the probe parallel to the shoulder during an in-plane ultrasound guided regional anesthesia technique.

NCT ID: NCT01688674 Terminated - Clinical trials for Once a Preterm Developed Hypoglycemia, no More Blood Glucose Was Measured During the Study Period.

Dextrose Infusion by Burettes Versus Dextrose Boluses in Prevention of Neonatal Hypoglycemia

Start date: February 2012
Phase: N/A
Study type: Interventional

NULL HYPOTHESIS • There is no difference in the incidence of hypoglycemia among preterms receiving either two hourly 10% dextrose boluses or 10% dextrose infusion by burettes during the 72 hours of admission in Special Care Unit- Mulago Hospital. ALTERNATE HYPOTHESIS • Use of two hourly 10% dextrose boluses increases the incidence of hypoglycemia by 30% compared to 10% dextrose infusion by burettes among preterms admitted to Special Care Unit in the first 72 hours of admission.

NCT ID: NCT01687543 Terminated - Clinical trials for Impact of Enteral Probiotics on Certain Lab Parameters

Probiotics for Reduction of Infections With Clostridium Difficile in Critically Ill Patients

ProbiEnt
Start date: June 2012
Phase: N/A
Study type: Interventional

Symptoms of Clostridium difficile infection is almost always induced as a complication to the use of antibiotics. Most ICU patients are given antibiotics. Probiotics has the ability to improve conditions in the gut and it has been shown in some smaller studies that overgrowth of C. difficile can be reduced or prevented. In this study the intention is to show with sufficient statistical power that a mixture of two otherwise well studied probiotic strains reduces or prevents the incidence of emerging colonisation with C. difficile in critical ill patients on antibiotics. Half of the patients will be given a mixture of Lactobacillus plantarum 299 and Lactobacillus plantarum 299v twice daily and the rest a placebo mixture. Rectal swabs or faeces will be analysed for C.difficile and its toxins and the incidence of new cases will be compared for the two groups. White blood cells (WBC´s), C reactive protein (CRP), lactate, urea, and creatinine will be followed daily as well as antibiotics, corticosteroids and all acid reducing medication. Nutrition, enteral and total, and bowel habits will be recorded.

NCT ID: NCT01685632 Terminated - Clinical trials for Peritoneal Carcinomatosis From Colorectal or Ovarian Origin

Intra Peritoneal Chemo Hyperthermia (IPCH) : Cellular and Metabolic Consequences

CHIP
Start date: September 2012
Phase: N/A
Study type: Interventional

Intra Peritoneal Chemo Hyperthermia (IPCH) is a recently validated option for the treatment of peritoneal carcinomatosis from colorectal or ovarian origin. This therapeutic program demonstrated a significant improvement of the late stages (i.e. carcinomatosis) of the disease. From a clinical point of view, within the first 24 hours after IPCH, patients undergo a systemic inflammatory response syndrome, and therefore require to be monitored in an intensive care unit. From a metabolic perspective, preliminary data have been shown a significant "anaerobic style" disturbance of energetic metabolism, suggesting a deep cellular energetic deficit throughout IPCH process. Putative contradictory effects of IPCH, like the increase of chemotherapy-related cellular toxicity due to heat and on the other hand the initiation of a stress protein response (heat shock response) which helps to reduce the cell injuries, leads to conduct a research project on the underlying mechanisms: consequences, in terms of patient's care and follow-up, are of high relevance. The primary goal is a multimodal assessment of the IPCH-related cell modifications: signaling pathways, apoptosis and antitumoral immune response. The assessment criteria include Heat shock protein expression (blood/cell ratio) compared to baseline values, apoptosis and immune response before/after IPCH. The scheduled sample size is 30 patients having an IPCH and 30 patients contraindicated per surgery.

NCT ID: NCT01685606 Terminated - Clinical trials for Mantle Cell Lymphoma

Study of Infusion of Blood Cells (Lymphocytes) to Stimulate the Immune System to Fight Leukemia/Lymphoma

273
Start date: March 2013
Phase: Phase 2
Study type: Interventional

The study of whether an infusion of blood cells called lymphocytes from a donor can stimulate the immune system to fight your leukemia/lymphoma.

NCT ID: NCT01685346 Terminated - Clinical trials for Advanced (Stage IV) Non-small Cell Lung Cancer (NSCLC)

Biofeedback Training in Patients With Advanced Lung Cancer - A Pilot Study

Start date: October 2012
Phase: N/A
Study type: Interventional

This is a pilot study to test the hypothesis that biofeedback-mediated stress management (BFSM) training can be used to reduce distress and enhance quality of life in patients with non-small cell lung cancer (NSCLC). Most patients with advanced NSCLC have significant physical symptoms, but even those who do not have physical symptoms have high levels of anxiety and depression.

NCT ID: NCT01684267 Terminated - Clinical trials for Gait Re-training in Stroke Survivors

Pelvic Obliquity Rehabilitation in Stroke Patients Using Robotically Generated Force Fields

Start date: January 2012
Phase: N/A
Study type: Interventional

To test the usability and effectiveness of a robotic device, called the Robotic Gait Rehabilitation (RGR) Trainer, in (1) healthy subjects with no gait impairment and (2) patients with stroke with gait abnormalities secondary to impaired knee function.

NCT ID: NCT01682590 Terminated - Septic Shock Clinical Trials

I.D.E.A.L.-I.C.U. (Initiation of Dialysis EArly Versus deLayed in Intensive Care Unit)

IDEAL-ICU
Start date: July 2012
Phase: Phase 3
Study type: Interventional

The purpose of this multicentric, randomized controlled trial is to assess whether the timing of renal replacement therapy initiation (early vs delayed) has an impact on mortality at 90 days in patients with severe acute kidney injury at the failure stage (according to RIFLE criteria) during the initial phase of septic shock.